会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Electronic device
    • 电子设备
    • US09369565B2
    • 2016-06-14
    • US14401459
    • 2012-07-12
    • Jun Katada
    • Jun Katada
    • H04M1/725H04W84/12H04W88/02H04W88/08
    • H04M1/7253H04M2250/02H04W84/12H04W88/02H04W88/08
    • An object of the present invention is to provide an electronic device which can output audio without sound skipping and can connect to the Internet. An electronic device according to the present invention includes: communication units that communicate with an outside by predetermined communication systems including a Bluetooth (registered trademark) communication; and a communication controller that controls to communicate with the outside by any of the predetermined communication systems, wherein the communication controller secures in advance an audio-dedicated band in a frequency band used in the Bluetooth communication.
    • 本发明的目的是提供一种电子设备,其可以在没有声音跳过的情况下输出音频并且可以连接到因特网。 根据本发明的电子设备包括:通过包括蓝牙(注册商标)通信的预定通信系统与外部通信的通信单元; 以及控制通过任何预定通信系统与外部进行通信的通信控制器,其中通信控制器预先确保在蓝牙通信中使用的频带中的音频专用频带。
    • 6. 发明授权
    • Platelet aggregation-inhibiting peptides
    • 血小板聚集抑制肽
    • US5498601A
    • 1996-03-12
    • US232261
    • 1994-05-06
    • Yoshimi SatoYoshio HayashiJun Katada
    • Yoshimi SatoYoshio HayashiJun Katada
    • A61K38/00A61P7/02C07K7/06C07K14/745C07K14/78A61K38/04C07K7/00
    • C07K14/78C07K14/745A61K38/00Y02P20/55
    • Novel peptide derivatives having RGD as a basic structure were found which have a platelet aggregation-inhibiting action, blood coagulation-inhibiting action and cell adhesion-inhibiting action.Utlizing these effects of the peptide derivatives, the following agents which comprise the peptides as active ingredients were provided: platelet aggregation-inhibiting agents that are effective in thrombolus during and after the treatment of thrombolysis and thromboembolism and that can further prevent reobstruction and cardiac infarction; blood coagulation-inhibiting agents that can inhibit blood coagulation which is the main cause of thrombus formation during extracorporeal circulation; cell adhesion-inhibiting agents; tumor metastasis-inhibiting agents; and agents for protecting platelet preparations for blood transfusion.In addition, the present invention intends to provide platelet preparation packs for blood transfusion, characterized in that the peptide dervatives are contained in platelet preparations for blood transfusion in packs.
    • PCT No.PCT / JP93 / 01262 Sec。 371日期:1994年5月6日 102(e)日期1994年5月6日PCT提交1993年9月7日PCT公布。 公开号WO94 / 05696 日期:1994年3月17日。发现具有RGD作为碱性结构的新型肽衍生物具有血小板聚集抑制作用,凝血抑制作用和细胞粘附抑制作用。 提供了肽衍生物的这些作用,提供了包含肽作为活性成分的以下药剂:血小板聚集抑制剂,其在治疗溶栓和血栓栓塞期间和之后都有效的血栓形成,并且可以进一步防止再梗塞和心肌梗死; 能够抑制血液凝固的血液凝固抑制剂,其是体外循环中血栓形成的主要原因; 细胞粘附抑制剂; 肿瘤转移抑制剂; 和用于保护输血血小板制剂的药剂。 此外,本发明意图提供用于输血的血小板制剂包,其特征在于肽衍生物包含在用于输液的包装的血小板制剂中。